Pages that link to "Q39313232"

The following pages link to Pocketcheck: updating the HLA class I peptide specificity roadmap (Q39313232):

Displayed 10 items.

• Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity (Q33789950) ‎ (← links)
• HLA-E: a novel player for histocompatibility (Q38268679) ‎ (← links)
• HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome (Q38835585) ‎ (← links)
• A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A(*)24 Allotypes (Q38895862) ‎ (← links)
• Soluble HLA technology as a strategy to evaluate the impact of HLA mismatches (Q39123538) ‎ (← links)
• Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices (Q40048119) ‎ (← links)
• Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease (Q47817333) ‎ (← links)
• Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B∗15:02 (Q57300409) ‎ (← links)
• The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection (Q58724946) ‎ (← links)
• The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity (Q90749291) ‎ (← links)